Evidence map›Paper›PMID 18359397›Full record

ArticleSeminars in nephrology2008

Nephrolithiasis after bariatric surgery for obesity.

John C Lieske, Rajiv Kumar, Maria L Collazo-Clavell

Abstract read
In one paragraph

Article in Seminars in nephrology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Prospective evaluation of urinary incontinence in severely obese adolescents presenting for weight loss surgery.Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery · 2018
    Article
  12. Bariatric Surgery and Kidney-Related Outcomes.Kidney international reports · 2017
    Article
  13. Enteric hyperoxaluria: an important cause of end-stage kidney disease.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2016
    Review
  14. Prospective evaluation of urinary metabolic indices in severely obese adolescents after weight loss surgery.Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery · 2016
    Article
  15. Review
  16. Article
  17. Subclinical celiac disease and crystal-induced kidney disease following kidney transplant.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2012
    Article
  18. Article
  19. Review
  20. Primary care of the renal transplant patient.Journal of general internal medicine · 2010
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

John C LieskeDepartment of Internal Medicine, Mayo Clinic College of Medicine Rochester, MN 55905, USA. Lieske.John@mayo.edu
Rajiv Kumar
Maria L Collazo-Clavell

Funding

ROCHESTER EPIDEMIOLOGY PROJECTR01AR030582 · NIAMS · MAYO CLINIC ROCHESTER · PI ROCCA, WALTER A · 1986 to 2009
$5.1M
ENTERIC PHYSIOLOGY OF THE TRANSPLANTED GUTR01DK039337 · NIDDK · MAYO CLINIC ROCHESTER · PI SARR, MICHAEL G · 1989 to 2007
$2.2M
Prevention of Renal Damage in Primary HyperoxaluriaR01DK073354 · NIDDK · MAYO CLINIC ROCHESTER · PI MILLINER, DAWN SCHMAUTZ · 2005 to 2008
$1.8M
REGULATIOIN OF RENAL PHOSPHATE EXCRETION AND VITAMIN D METABOLISM BY FGF 7R01DK076829 · NIDDK · MAYO CLINIC ROCHESTER · PI KUMAR, RAJIV · 2007 to 2010
$1.2M
Use of symbiotics to reduce urinary oxalate excretionR21AT002534 · NCCIH · MAYO CLINIC ROCHESTER · PI LIESKE, JOHN C · 2005 to 2007
$579k
Hyperoxaluria and Nephrolithiasis After Gastric Bypass Surgery for ObesityR21DK077669 · NIDDK · MAYO CLINIC ROCHESTER · PI KUMAR, RAJIV · 2007 to 2008
$412k
NCCIH NIH HHS AT 002534NCCIH NIH HHS R21 AT002534NIAMS NIH HHS AR 30582NIAMS NIH HHS R01 AR030582NIDDK NIH HHS DK 39337NIDDK NIH HHS DK 73354NIDDK NIH HHS DK 77669NIDDK NIH HHS R01 DK039337NIDDK NIH HHS R01 DK073354NIDDK NIH HHS R01 DK076829NIDDK NIH HHS R21 DK077669
6 · The paper itself

Abstract

Surgical intervention has become an accepted therapeutic alternative for the patient with medically complicated obesity. Multiple investigators have reported significant and sustained weight loss after bariatric surgery that is associated with improvement of many weight-related medical comorbidities, and statistically significant decreased overall mortality for surgically treated as compared with medically treated subjects. Although the Roux-en-Y gastric bypass (RYGB) is considered an acceptably safe treatment, an increasing number of patients are being recognized with nephrolithiasis after this, the most common bariatric surgery currently performed. The main risk factor appears to be hyperoxaluria, although low urine volume and citrate concentrations may contribute. The incidence of these urinary risk factors among the total post-RYGB population is unknown, but may be more than previously suspected based on small pilot studies. The etiology of the hyperoxaluria is unknown, but may be related to subtle and seemingly subclinical fat malabsorption. Clearly, further study is needed, especially to define better treatment options than the standard advice for a low-fat, low-oxalate diet, and use of calcium as an oxalate binder.

Indexed as

Gastric BypassHumansHyperoxaluriaKidney CalculiNephrolithiasisObesity, Morbid

Identifiers

PMID18359397
PMCPMC2831413

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.